4//SEC Filing
Lamy Patrick 4
Accession 0000950170-25-088639
CIK 0001744659other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 9:08 PM ET
Size
4.9 KB
Accession
0000950170-25-088639
Insider Transaction Report
Form 4
Lamy Patrick
Senior VP, Commercial Strategy
Transactions
- Sale
Common Stock
2025-06-20$54.59/sh−875$47,766→ 31,698 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. Such sales were automatic and not at the discretion of the Reporting Person.
Documents
Issuer
Akero Therapeutics, Inc.
CIK 0001744659
Entity typeother
Related Parties
1- filerCIK 0001961273
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 9:08 PM ET
- Size
- 4.9 KB